{"name":"Cecilia Soderberg-Naucler","slug":"cecilia-soderberg-naucler","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMickFVX3lxTE5sV3hLY0o2cU5xVUd3UWFoa3dQemRoaFozTWl0SHIxdldMT1J5UWdKT0VQdTVZSFVldUlUMTZIbFVYZEVjeFM5U0NUUHVKbGRBS2E2T3I2cUllZlNwVUgzTXdZaGtpOWlGNFFEZ3dCMW1PUQ?oc=5","date":"2022-09-01","type":"pipeline","source":"medRxiv","summary":"Influenza A H1N1–mediated pre-existing immunity to SARS-CoV-2 predicts COVID-19 outbreak dynamics - medRxiv","headline":"Influenza A H1N1–mediated pre-existing immunity to SARS-CoV-2 predicts COVID-19 outbreak dynamics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMidEFVX3lxTE1GejNuQ2ZBZWU0UEFMWjN0U2owbnc4MXJZZFF4d3RFY0ZhaFdDbGRDLUZXbXpwUHAyRGxsaDRnWUlET1pRWEx6Qm1aLXU4ODRWS3pMNmdDOFdDcnVsWmJYcm9FUDQ5SEI3dmVUbHpFcTBaaFVF?oc=5","date":"2021-07-13","type":"pipeline","source":"medRxiv","summary":"Indications that Stockholm has reached herd immunity, given limited restrictions, against several variants of SARS-CoV-2 - medRxiv","headline":"Indications that Stockholm has reached herd immunity, given limited restrictions, against several variants of SARS-CoV-2","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}